ORIC Pharmaceuticals, Inc. (ORIC) Tops Q1 EPS by 5c

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported Q1 EPS of ($0.37), $0.05 better than the analyst estimate of ($0.42).

For earnings history and earnings-related data on ORIC Pharmaceuticals, Inc. (ORIC) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)
• INVO Fertility (IVF) Tops Q2 EPS by 105c